2026-2034年全球血液透析血管移植市场规模、份额、趋势和成长分析报告

预计血液透析血管移植市场将从 2025 年的 2.8677 亿美元成长到 2034 年的 4.3282 亿美元，2026 年至 2034 年的复合年增长率为 4.68%。

由于慢性肾臟病和末期肾功能衰竭的盛行率不断上升，全球血液透析血管移植市场正经历稳定成长。血管移植对于建立可靠的血管通路以进行长期透析治疗至关重要。人口老化以及糖尿病和高血压盛行率的上升是主要推动因素。

成长要素包括移植材料的技术进步、生物相容性的提升以及抗感染能力的增强。透析中心的扩建和开发中国家医疗保健服务的改善也支持了市场需求。然而，血栓症和感染疾病等併发症仍然是影响临床疗效的挑战。

展望未来，透过合成和生物工程技术实现移植材料的创新有望提高其耐久性和患者安全性。肾臟护理基础设施投资的增加将进一步推动市场需求。随着全球肾臟疾病发生率的持续上升，血管移植材料解决方案将继续在治疗通讯协定中发挥关键作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球血液透析血管移植物市场：依原料划分

• 市场分析、洞察与预测
• 聚酯纤维
• 聚四氟乙烯
• 聚氨酯
• 生物材料

第五章 全球血液透析血管移植市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 门诊治疗中心
• 其他的

第六章 全球血液透析血管移植市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • WL Gore & Associates
  • CR BardInc
  • Terumo Medical Corporation
  • LeMaitre VascularInc
  • Getinge AB
  • Vascular Genesis
  • InnAVasc MedicalInc
  • CryoLifeInc
  • Merit Medical SystemsInc
  • Proteon TherapeuticsInc

The Hemodialysis Vascular Grafts Market size is expected to reach USD 432.82 Million in 2034 from USD 286.77 Million (2025) growing at a CAGR of 4.68% during 2026-2034.

The global hemodialysis vascular grafts market is witnessing steady growth due to the rising prevalence of chronic kidney disease and end-stage renal disease. Vascular grafts are essential for establishing reliable vascular access for long-term dialysis treatment. Aging populations and increasing incidence of diabetes and hypertension are key contributing factors.

Growth drivers include technological advancements in graft materials, improved biocompatibility, and better infection resistance. Expanding dialysis centers and improved healthcare access in developing countries support market demand. However, complications such as thrombosis and infection remain challenges for clinical outcomes.

Looking ahead, innovation in synthetic and bioengineered graft materials is expected to enhance durability and patient safety. Growing investment in renal care infrastructure will further strengthen demand. As global kidney disease rates continue to rise, vascular graft solutions will remain critical in treatment protocols.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Raw Materials

• Polyester
• Polytetrafluoroethylene
• Polyurethane
• Biological Materials

By End User

• Hospitals
• Ambulatory Care Centers
• Others

COMPANIES PROFILED

• WL Gore Associates, CR Bard, Inc, Terumo Medical Corporation, LeMaitre Vascular, Inc, Getinge AB, Vascular Genesis, InnAVasc Medical, Inc, CryoLife, Inc, Merit Medical Systems, Inc, Proteon Therapeutics, Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEMODIALYSIS VASCULAR GRAFTS MARKET: BY RAW MATERIALS 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Raw Materials
• 4.2. Polyester Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Polytetrafluoroethylene Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Polyurethane Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Biological Materials Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEMODIALYSIS VASCULAR GRAFTS MARKET: BY END USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End User
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Ambulatory Care Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEMODIALYSIS VASCULAR GRAFTS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Raw Materials
  • 6.2.2 By End User
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Raw Materials
  • 6.3.2 By End User
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Raw Materials
  • 6.4.2 By End User
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Raw Materials
  • 6.5.2 By End User
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Raw Materials
  • 6.6.2 By End User
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL HEMODIALYSIS VASCULAR GRAFTS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 W.L. Gore & Associates
  • 8.2.2 C.R. BardInc
  • 8.2.3 Terumo Medical Corporation
  • 8.2.4 LeMaitre VascularInc
  • 8.2.5 Getinge AB
  • 8.2.6 Vascular Genesis
  • 8.2.7 InnAVasc MedicalInc
  • 8.2.8 CryoLifeInc
  • 8.2.9 Merit Medical SystemsInc
  • 8.2.10 Proteon TherapeuticsInc